Literature DB >> 17122193

Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse.

Patrick Yue1, Takayasu Arai, Masahiro Terashima, Ahmad Y Sheikh, Feng Cao, David Charo, Grant Hoyt, Robert C Robbins, Euan A Ashley, Joseph Wu, Phillip C Yang, Philip S Tsao.   

Abstract

The db/db mouse is a well-established model of diabetes. Previous reports have documented contractile dysfunction (i.e., cardiomyopathy) in these animals, although the extant literature provides limited insights into cardiac structure and function as they change over time. To better elucidate the natural history of cardiomyopathy in db/db mice, we performed cardiac magnetic resonance (CMR) scans on these animals. CMR imaging was conducted with a 4.7-T magnet on female db/db mice and control db/+ littermates at 5, 9, 13, 17, and 22 wk of age. Gated gradient echo sequences were used to obtain cineographic short-axis slices from apex to base. From these images left ventricular (LV) mass (LVM), wall thickness, end-diastolic volume (LVEDV), and ejection fraction (LVEF) were determined. Additionally, cardiac [(18)F]fluorodeoxyglucose ([(18)F]FDG) PET scanning, pressure-volume loops, and real-time quantitative PCR on db/db myocardium were performed. Relative to control, db/db mice developed significant increases in LVM and wall thickness as early as 9 wk of age. LVEDV diverged slightly later, at 13 wk. Interestingly, compared with the baseline level, LVEF in the db/db group did not decrease significantly until 22 wk. Additionally, [(18)F]FDG metabolic imaging showed a 40% decrease in glucose uptake in db/db mice. Furthermore, contractile dysfunction was observed in 15-wk db/db mice undergoing pressure-volume loops. Finally, real-time quantitative PCR revealed an age-dependent recapitulation of the fetal gene program, consistent with a myopathic process. In summary, as assessed by CMR, db/db mice develop characteristic structural and functional changes consistent with cardiomyopathy.

Entities:  

Mesh:

Year:  2006        PMID: 17122193     DOI: 10.1152/ajpheart.00856.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

Review 1.  Type 2 diabetes, mitochondrial biology and the heart.

Authors:  Michael N Sack
Journal:  J Mol Cell Cardiol       Date:  2009-02-13       Impact factor: 5.000

2.  Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT.

Authors:  Blake J Cochran; William J Ryder; Arvind Parmar; Kerstin Klaeser; Anthonin Reilhac; Georgios I Angelis; Steven R Meikle; Philip J Barter; Kerry-Anne Rye
Journal:  J Vis Exp       Date:  2017-05-02       Impact factor: 1.355

3.  Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.

Authors:  Hanrui Zhang; Brandon Morgan; Barry J Potter; Lixin Ma; Kevin C Dellsperger; Zoltan Ungvari; Cuihua Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

4.  Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.

Authors:  Jordan J Wright; Jaetaek Kim; Jonathan Buchanan; Sihem Boudina; Sandra Sena; Kyriaki Bakirtzi; Olesya Ilkun; Heather A Theobald; Robert C Cooksey; Kostantin V Kandror; E Dale Abel
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

5.  Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation.

Authors:  Michael E Hall; Matthew W Maready; John E Hall; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-17       Impact factor: 4.310

6.  Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair.

Authors:  Sadia Mohsin; Mohsin Khan; Haruhiro Toko; Brandi Bailey; Christopher T Cottage; Kathleen Wallach; Divya Nag; Andrew Lee; Sailay Siddiqi; Feng Lan; Kimberlee M Fischer; Natalie Gude; Pearl Quijada; Daniele Avitabile; Silvia Truffa; Brett Collins; Walter Dembitsky; Joseph C Wu; Mark A Sussman
Journal:  J Am Coll Cardiol       Date:  2012-07-26       Impact factor: 24.094

7.  In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.

Authors:  Blake J Cochran; William J Ryder; Arvind Parmar; Shudi Tang; Anthonin Reilhac; Andrew Arthur; Arnaud Charil; Hasar Hamze; Philip J Barter; Leonard Kritharides; Steven R Meikle; Marie-Claude Gregoire; Kerry-Anne Rye
Journal:  Diabetologia       Date:  2016-05-18       Impact factor: 10.122

8.  Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements.

Authors:  John E Porterfield; Anil T G Kottam; Karthik Raghavan; Daniel Escobedo; James T Jenkins; Erik R Larson; Rodolfo J Treviño; Jonathan W Valvano; John A Pearce; Marc D Feldman
Journal:  J Appl Physiol (1985)       Date:  2009-08-20

9.  Apelin is necessary for the maintenance of insulin sensitivity.

Authors:  Patrick Yue; Hong Jin; Marissa Aillaud; Alicia C Deng; Junya Azuma; Tomoko Asagami; Ramendra K Kundu; Gerald M Reaven; Thomas Quertermous; Philip S Tsao
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10-27       Impact factor: 4.310

10.  A new mouse model of metabolic syndrome and associated complications.

Authors:  Yun Wang; Yue Zheng; Patsy M Nishina; Jürgen K Naggert
Journal:  J Endocrinol       Date:  2009-04-27       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.